Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.

Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder caused by mutations in the dystrophin gene that result in the absence of functional protein. Antisense-mediated exon skipping is one of the most promising approaches for the treatment of DMD and recent clinical trials have demonstr...

ver descrição completa

Detalhes bibliográficos
Main Authors: Goyenvalle, A, Babbs, A, Wright, J, Wilkins, V, Powell, D, Garcia, L, Davies, K
Formato: Conference item
Publicado em: 2012
_version_ 1826283600481353728
author Goyenvalle, A
Babbs, A
Wright, J
Wilkins, V
Powell, D
Garcia, L
Davies, K
author_facet Goyenvalle, A
Babbs, A
Wright, J
Wilkins, V
Powell, D
Garcia, L
Davies, K
author_sort Goyenvalle, A
collection OXFORD
description Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder caused by mutations in the dystrophin gene that result in the absence of functional protein. Antisense-mediated exon skipping is one of the most promising approaches for the treatment of DMD and recent clinical trials have demonstrated encouraging results. However, antisense oligonucleotide-mediated exon skipping for DMD still faces major hurdles such as extremely low efficacy in the cardiac muscle, poor cellular uptake and relatively rapid clearance from circulation, which means that repeated administrations are required to achieve some therapeutic efficacy. To overcome these limitations, we previously proposed the use of small nuclear RNAs (snRNAs), especially U7snRNA to shuttle the antisense sequences after vectorization into adeno-associated virus (AAV) vectors. In this study, we report for the first time the efficiency of the AAV-mediated exon skipping approach in the utrophin/dystrophin double-knockout (dKO) mouse which is a very severe and progressive mouse model of DMD. Following a single intravenous injection of scAAV9-U7ex23 in dKO mice, near-normal levels of dystrophin expression were restored in all muscles examined, including the heart. This resulted in a considerable improvement of their muscle function and dystrophic pathology as well as a remarkable extension of the dKO mice lifespan. These findings suggest great potential for AAV-U7 in systemic treatment of the DMD phenotype.
first_indexed 2024-03-07T01:01:18Z
format Conference item
id oxford-uuid:89d42f7e-5976-401f-962e-fb3d29e94b53
institution University of Oxford
last_indexed 2024-03-07T01:01:18Z
publishDate 2012
record_format dspace
spelling oxford-uuid:89d42f7e-5976-401f-962e-fb3d29e94b532022-03-26T22:27:17ZRescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.Conference itemhttp://purl.org/coar/resource_type/c_5794uuid:89d42f7e-5976-401f-962e-fb3d29e94b53Symplectic Elements at Oxford2012Goyenvalle, ABabbs, AWright, JWilkins, VPowell, DGarcia, LDavies, KDuchenne muscular dystrophy (DMD) is a severe neuromuscular disorder caused by mutations in the dystrophin gene that result in the absence of functional protein. Antisense-mediated exon skipping is one of the most promising approaches for the treatment of DMD and recent clinical trials have demonstrated encouraging results. However, antisense oligonucleotide-mediated exon skipping for DMD still faces major hurdles such as extremely low efficacy in the cardiac muscle, poor cellular uptake and relatively rapid clearance from circulation, which means that repeated administrations are required to achieve some therapeutic efficacy. To overcome these limitations, we previously proposed the use of small nuclear RNAs (snRNAs), especially U7snRNA to shuttle the antisense sequences after vectorization into adeno-associated virus (AAV) vectors. In this study, we report for the first time the efficiency of the AAV-mediated exon skipping approach in the utrophin/dystrophin double-knockout (dKO) mouse which is a very severe and progressive mouse model of DMD. Following a single intravenous injection of scAAV9-U7ex23 in dKO mice, near-normal levels of dystrophin expression were restored in all muscles examined, including the heart. This resulted in a considerable improvement of their muscle function and dystrophic pathology as well as a remarkable extension of the dKO mice lifespan. These findings suggest great potential for AAV-U7 in systemic treatment of the DMD phenotype.
spellingShingle Goyenvalle, A
Babbs, A
Wright, J
Wilkins, V
Powell, D
Garcia, L
Davies, K
Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
title Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
title_full Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
title_fullStr Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
title_full_unstemmed Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
title_short Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
title_sort rescue of severely affected dystrophin utrophin deficient mice through scaav u7snrna mediated exon skipping
work_keys_str_mv AT goyenvallea rescueofseverelyaffecteddystrophinutrophindeficientmicethroughscaavu7snrnamediatedexonskipping
AT babbsa rescueofseverelyaffecteddystrophinutrophindeficientmicethroughscaavu7snrnamediatedexonskipping
AT wrightj rescueofseverelyaffecteddystrophinutrophindeficientmicethroughscaavu7snrnamediatedexonskipping
AT wilkinsv rescueofseverelyaffecteddystrophinutrophindeficientmicethroughscaavu7snrnamediatedexonskipping
AT powelld rescueofseverelyaffecteddystrophinutrophindeficientmicethroughscaavu7snrnamediatedexonskipping
AT garcial rescueofseverelyaffecteddystrophinutrophindeficientmicethroughscaavu7snrnamediatedexonskipping
AT daviesk rescueofseverelyaffecteddystrophinutrophindeficientmicethroughscaavu7snrnamediatedexonskipping